Monitoring Drug-induced Myocarditis (CardiTOX)
NCT03855982 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6000
Last updated 2023-04-05
Summary
Several drugs and chemotherapies seem to induce myocarditis. This study investigates reports of myocarditis, including the International classification of disease ICD-10 for treatments in the World Health Organization (WHO) global Individual Case Safety Report (ICSR) database (VigiBase).
Conditions
- Myocarditis
- Myocardial Failure
- Myocardial Dysfunction
Interventions
- DRUG
-
Drug inducing myocarditis
Drugs susceptible to induce myocarditis
Sponsors & Collaborators
-
Groupe Hospitalier Pitie-Salpetriere
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-04-09
- Primary Completion
- 2020-02-25
- Completion
- 2023-04-04
- FDA Drug
- Yes
Countries
- France
Study Locations
More Related Trials
-
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
NCT04166331 ·Status: COMPLETED ·Phase: PHASE3
-
Corticoid Therapy in Acute Myocarditis
NCT06522100 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Drug-Induced Sudden Death & Ventricular Arrhythmia
NCT00102180 ·Status: COMPLETED
-
Colchicine Versus Placebo in Acute Myocarditis Patients
NCT05855746 ·Status: RECRUITING ·Phase: PHASE3
-
Abatacept in Immune Checkpoint Inhibitor Myocarditis
NCT05335928 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation and Management of Cardio Toxicity in Oncologic Patients
NCT02818517 ·Status: RECRUITING
-
Study to Assess Efficacy and Safety of CDR132L in Patients With Reduced Left Ventricular Ejection Fraction After Myocardial Infarction
NCT05350969 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Study of AG10 in Patients with Cardiomyopathy
NCT03536767 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180
NCT00907998 ·Status: COMPLETED ·Phase: PHASE1
-
Nitrate's Effect on Activity Tolerance in Heart Failure With Preserved Ejection Fraction
NCT02053493 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)
NCT06591260 ·Status: RECRUITING
-
Detection of Chemotherapy Induced Cardiotoxicity
NCT00636844 ·Status: COMPLETED
-
The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy
NCT05961202 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Drug Drug Interaction (DDI) Study of Baricitinib (LY3009104) and Digoxin in Healthy Participants
NCT01859078 ·Status: COMPLETED ·Phase: PHASE1
-
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
NCT05610423 ·Status: ENROLLING_BY_INVITATION
-
Myocardial Fibrosis Identification in Patients With Anthracycline-induced Cardiotoxicity
NCT06331806 ·Status: RECRUITING ·Phase: NA
-
Medications and the Risk of Sudden Cardiac Death
NCT00241800 ·Status: COMPLETED
-
Prevention and Pharmacological Management of Cardiac Adverse Drug Reactions Induced by Drugs Used in Oncology.
NCT03678337 ·Status: UNKNOWN
-
Phase I Interaction Study of Istaroxime and Digoxin in Subjects With Stable Heart Failure
NCT00869115 ·Status: WITHDRAWN ·Phase: PHASE1
-
CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices
NCT03217331 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
NCT05724121 ·Status: RECRUITING
-
Evaluation of Reporting of Cardio-vascular Adverse Events With Antineoplastic and Immunomodulating Agents (EROCA)
NCT03530215 ·Status: COMPLETED
-
Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction
NCT02046044 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
NCT01935622 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Continuous Infusions of HNO (Nitroxyl) Donor in Patients With Heart Failure and Impaired Systolic Function
NCT03357731 ·Status: COMPLETED ·Phase: PHASE2